Riskpilot← Back to searchSign inGet full accessMCAP Biotech Invest A/S
A/SActiveCVR 41435534Pilestræde 52A, 1.Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2020— employees
Revenue 2024
—
EBITDA margin
—
-478% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK -11K
+100% vs 2023
| Revenue | — | — |
| EBITDA | DKK -11K | -478% |
| Net profit | DKK -11K | +100% |
| Total assets | DKK 476K | +6% |
| Equity | DKK 476K | +9% |
| Employees | — | — |
Legal name
MCAP Biotech Invest A/S
CVR number
41435534
Legal form
Aktieselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
12. juni 2020
Share capital
DKK 950.710
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at investere i Oryx GmbH & Co. KG gennem selskabet Eriksdal Holding Sarl.
Address
Pilestræde 52A, 1.
Email
uwe@investor-luxembourg.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -16 | -1 | 0 | 3 | -10 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -16 | -1 | 0 | 3 | -10 |
| Net financials | 3.988 | 0 | 0 | -4.438 | 0 |
| Profit before tax | 3.972 | -1 | 0 | -4.435 | -10 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 3.972 | -1 | 0 | -4.435 | -10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4.889 | 4.889 | 4.878 | 449 | 476 |
| Equity | 4.873 | 4.872 | 4.872 | 437 | 476 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 16 | 17 | 6 | 12 | 0 |
| Total debt | 16 | 17 | 6 | 12 | 0 |
EBITDA margin
-1050000.0%
This company
15.8%
Market median
-6645670% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-2.2%
This company
18.4%
Market median
-112% vs market
20202024
Net profit margin
-1050000.0%
This company
8.1%
Market median
-12963063% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-06-12 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PB Management | Management | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 10–14.99% | 10–14.99% | 2020 | |
| Company | 10–14.99% | 10–14.99% | 2020 | |
| Company | 10–14.99% | 10–14.99% | 2020 | |
| Company | 10–14.99% | 10–14.99% | 2020 | |
| Company | 10–14.99% | 10–14.99% | 2020 | |
| Individual | 10–14.99% | 10–14.99% | 2020 | |
| Company | 10–14.99% | 10–14.99% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PAN HOLDING ApS
MCAP Biotech Invest A/S Board members of MCAP Biotech Invest A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Borre Møller | Management | 0 companies |
| Christian Winther Sørensen | Chairman | 0 companies |
| Mats Johan Willman | Chairman | 0 companies |
| Magnus Sandqvist | Board of Directors | 0 companies |
| Morten Borre Møller Rosenskjold | Board of Directors | 0 companies |
| Kai-Uwe Jens Nielsen | Board of Directors | 0 companies |